Sixty-seven percent and 25% of 48 children with peanut allergy ages 1 to 11 who received sublingual immunotherapy ate at least 750 mg and 5,000 mg of peanut protein without developing clinical symptoms, respectively, researchers reported in The Journal of Allergy and Clinical Immunology. The findings also showed that transient oropharyngeal itching was the most prevalent side effect of SLIT, but only few side effects required antihistamine treatment.
Sublingual immunotherapy may benefit youths with peanut allergy
Sign up for Inform SmartBrief
Global fats and oils news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.